XORTX Therapeutics, Inc. (XRTX)

1.41 -0.44 (-23.78%) USD  |  NASDAQ  |  Oct 09, 16:00
1.47 +0.06 (+4.26%) After-Hours: 20:00
More

XORTX Therapeutics Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for XRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2022. Start Trial.
Date Value
September 18, 2025 --
February 25, 2025 --
Date Value
April 22, 2022 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Lexaria Bioscience Corp. Upgrade
InMed Pharmaceuticals, Inc. Upgrade
Target Group, Inc. (Canada) --
NervGen Pharma Corp. Upgrade
Milestone Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade